RESUMO
Infection with Strongyloides stercoralis is often asymptomatic but can be life-threatening in immunocompromised patients, which can be prevented by ivermectin (IVM) treatment. The efficacy of IVM has been reported to have lessened over time in some regions as a consequence of prolonged use and mass treatment campaigns. Ivermectin has been used in Thailand for more than a decade; therefore, we investigated the efficacy of a single dose (200 µg/kg) of IVM against in asymptomatic strongyloidiasis in northeastern Thailand. Fecal samples were collected before and 2 weeks after treatment and were analyzed for the presence of Strongyloides using a modified agar plate culture and the formalin-ethyl acetate concentration technique. Our results showed that single-dose IVM treatment successfully eliminated S. stercoralis infection in asymptomatic individuals in the endemic area with a 100% cure rate, indicating the high efficacy of IVM treatment in strongyloidiasis in northeast Thailand.
Assuntos
Fezes , Ivermectina , Strongyloides stercoralis , Estrongiloidíase , Ivermectina/uso terapêutico , Estrongiloidíase/tratamento farmacológico , Humanos , Animais , Strongyloides stercoralis/efeitos dos fármacos , Tailândia , Fezes/parasitologia , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Antiparasitários/uso terapêutico , Adulto Jovem , Adolescente , Resultado do TratamentoRESUMO
Patients with AIDS are prome to develop infections caused by opportunistic pathogens. Unusual agents, such as Stongyloides stercoralis, are being described in this syndrome, resulting in disseminated disease which is always severe and, in some cases, fatal. We describe a case of patient with AIDS and Strongyloides stercoralis infection involving the gastrointestinal tract and lungs. Therapy with thiabendazole for ten days led to resolution of the acute episode. Preventive therapy with 3g of thiabendazole once a week was then prescribed, and repeated fecal examinations were negative for larvae. Following discontinuation of treatment, however, the patient again had a positive fecal examination for Strongyloides stercoralis larvae, even though reinfection was considered to be very unlikely. The patient was retreated with a shorter course of therapy and once per week preventive therapy was reintroduced. After four months of follow-up, repeated fecal examinations were negative. When the treatment was changed to thiabendazole given once every two weeks, however, pulmonary Strongyloides stercoralis recurred. Subsequently, because of intolerance to thiabendazole, the patient was treated with cambendazole. The patient died three months later due to Pseudomonas aeruginosa pneumonia. Prolonged therapy for Strongyloides stercoralis infection may be necessary. Although further evaluation is needed, 3g of thiabendazole once a week may be adequate for this purpose. Cambendazole may be a useful alternative for disseminated Strongyloides stercoralis.
Assuntos
Humanos , Masculino , Adulto , Cambendazol/uso terapêutico , Estrongiloidíase/complicações , Estrongiloidíase/tratamento farmacológico , Hospedeiro Imunocomprometido , Síndrome da Imunodeficiência Adquirida/imunologia , Strongyloides stercoralis/efeitos dos fármacos , Tiabendazol/uso terapêutico , Infecções Oportunistas Relacionadas com a AIDS , Sistema Digestório/patologia , Fezes/parasitologia , Pneumonia Bacteriana/mortalidade , Pulmão/patologiaRESUMO
La strongyloidiasis se diagnostica rutinariamente por el examen directo de las heces del paciente. Esta no es la mejor ni la única manera de dilucidar la enfermedad, pues actualmente se cuenta con métodos inmunológicos indirectos y técnicas directas más sensibles y confiables que permiten la mayor captación de casos agudos y portadores crónicos de la infección